SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
小灰熊
Lv1
36 积分
2024-07-03 加入
最近求助
最近应助
互助留言
Advanced AI-Driven Prediction of Pregnancy-Related Adverse Drug Reactions
1天前
已完结
Comparative analysis of CDKI-related adverse events in older patients: a real-world data from the FDA adverse event reporting system database
5个月前
已完结
Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system
5个月前
已完结
Simultaneous Quantification of Vancomycin, Linezolid and Voriconazole in Human Plasma by UHPLC–MS/MS: Application in Therapeutic Drug Monitoring
6个月前
已完结
Simultaneous Quantitation of Anlotinib and Osimertinib by Isotope-Labeled UHPLC–MS/MS in Human Plasma: Application in NSCLC Patients
6个月前
已完结
Systematic review with meta‐analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor
7个月前
已完结
Vedolizumab versus ustekinumab in Crohn’s disease with prior anti-tumor necrosis factor failure: an updated meta-analysis
7个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
8个月前
已完结
Systematic review with meta‐analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor
9个月前
已完结
Systematic review with meta‐analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor
9个月前
已完结
没有进行任何应助
速度真快
5小时前
速度真快
6个月前
感谢
7个月前
感谢
7个月前
感谢
8个月前
感谢
1年前
感谢,速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论